Colon cancer screening rates continue to lag behind those for breast and cervical cancer. In an editorial in the February 20 edition of the Annals of Internal Medicine, Indiana University School of Medicine gastroenterologist and Regenstrief Institute, Inc. researcher Thomas Imperiale, M.D., writes that to increase screening rates for colorectal cancers, we need more convenient and less invasive screening tests. An infrequently used type of fecal sampling test, which has had Federal Drug Administration approval since 2001, may meet that need he says.
Bron: ScienceDaily Headlines
Daily headlines about discoveries in the physical and life sciences, health and medicine, the environment, and technology, from the world's leading universities and research centers.
Colon Cancer Screening: Going 'Back To The Future'?
0 gebruiker(s) lezen dit onderwerp
0 leden, 0 bezoekers, 0 anonieme gebruikers
Ook adverteren op onze website? Lees hier meer!
- Hier ook uw vacature? 06-14